Interfacing Chemical Biology and Drug Discovery
54th International Conference on Medicinal Chemistry
54èmes Rencontres Internationales de Chimie Thérapeutique
Strasbourg, France July 4-6, 2018
Registration
Opening and Inaugural Lecture
Session Chair
PL01 - Disrupting Cancer Care & Outcomes by Putting Patients in the Driving Seat
Session Chair
PL02 - Chemogenetic Approachs to Validate Poorly Characterised GPCRS
Coffee break and Exhibition
Session Chair
PL03 - Discovery of Balovaptan, a Vasopressin 1a Receptor Antagonist for the Treatment of Autism
PL04 - Ghrelin Receptor Ligands: from the Bench to the Drug on the Market
Lunch
Poster session and Exhibition
Session Chair
PL05 - Structure-Based Drug Discovery for G Protein-Coupled Purine Receptors
PL06 - Structure-guided Development of Selective GPCR Ligands
Coffee break and Exhibition
PL07 - Late Stage Fluorination for Medicine
PL08 - Single Electron Processes Enabling Organic Synthesis
Welcome and networking reception
Session Chair
PL09 - Paul Ehrlich Award Lecture - Chemical Biology on the Genome
Start of sessions
Coffee break and Exhibition
Start of sessions
Lunch
Poster session and Exhibition
Career Session
Start of sessions
Coffee break and Exhibition
Start of sessions
Banquet
Session Chair
PL20 - The Confobody Technology, a New Platform to Enable Fragment Screening on GPCRs
PL21 - Pierre Fabre Award lecture
PROTAC-mediated Protein Degradation: A New Therapeutic Modality
Coffee break and Exhibition
Session Chair
PL22 - Two Adventures in Chemical Biology - in vivo Chemistry and Real-time Optical Medical Imaging
Concluding remarks